 |
 |

CD8+ Epidermotropic Cytotoxic T-Cell Lymphoma With Peripheral Blood and Central Nervous System Involvement
Camille E. Introcaso, MD;
Ellen J. Kim, MD;
Jennifer Gardner, MD;
Jacqueline M. Junkins-Hopkins, MD;
Carmela C. Vittorio, MD;
Alain H. Rook, MD
Arch Dermatol. 2008;144(8):1027-1029.
Background Most cutaneous T-cell lymphomas demonstrate a malignant population with a CD4+ phenotype. In rare cases, CD8+ phenotypes have been described based on immunostaining of skin specimens. Although some CD8+ lymphomas have an indolent course, others, such as CD8+ epidermotropic cytotoxic T-cell lymphomas, are typically more aggressive. To our knowledge, involvement of peripheral blood or cerebrospinal fluid with a malignant population of CD8+ cells demonstrated by flow cytometry and T-cell receptor gene rearrangement has not been previously described.
Observations We describe a patient with a CD8+ cutaneous T-cell lymphoma with an initially indolent course and early stage diagnosed on the basis of a skin biopsy specimen. However, when flow cytometry was performed looking specifically at CD8+/CD4– cells in the peripheral blood and cerebrospinal fluid, a malignant population of CD8+/CD4–/CD26–/CD7– cells was discovered.
Conclusions It is important for prognosis and treatment to be able to identify CD8+ epidermotropic cytotoxic T-cell lymphoma and separate it from other relatively indolent CD8+ lymphomas. Furthermore, detection of an abnormal CD8+/CD26–/CD7– T-cell population within the peripheral blood has important prognostic and therapeutic implications. The use of flow cytometry looking for abnormal CD8+ populations in the peripheral blood or cerebrospinal fluid can assist with this critical information.
Author Affiliations: Department of Dermatology, Hospital of the University of Pennsylvania, Philadelphia.
CiteULike Connotea Delicious Digg Facebook Reddit Technorati Twitter
What's this?
RELATED ARTICLE
This Month in Archives of Dermatology
Arch Dermatol. 2008;144(8):978.
FULL TEXT
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Constitutive JAK3 activation induces lymphoproliferative syndromes in murine bone marrow transplantation models
Cornejo et al.
Blood 2009;113:2746-2754.
ABSTRACT
| FULL TEXT
|